TUMORVUE

Welcome to the Brand page for “TUMORVUE”, which is offered here for Radiopharmaceutical and imaging and detection agent for diagnosing and monitoring diseases, noninvasive agent for whole body targeting of treatment response for clinical applications for cancer and cardiovascular diseases;tumor view;.

Its status is currently believed to be active. Its class is unavailable. “TUMORVUE” is believed to be currently owned by “Molecular Targeting Technologies, Inc.”

Owner:
MOLECULAR TARGETING TECHNOLOGIES, INC.
Owner Details
Description:
Radiopharmaceutical and imaging and detection agent for diagnosing and monitoring diseases, noninvasive agent for whole body targeting of treatment response for clinical applications for cancer and cardiovascular diseases;TUMOR VIEW;
Categories: RADIOPHARMACEUTICAL IMAGING DETECTION